COVID-19 Update
In line with international standards to provide you with the safest environment, we have introduced the following additional precautionary measures at our facilities:
800 42532 (ICLDC)
F: +971 2 404 0900
PO Box 48338
Al Khaleej Al Arabi Street
Beside Zayed Military Hospital
Abu Dhabi, United Arab Emirates
T: 800 42532 (ICLDC)
F: +971 2 404 0900
PO Box 48338
Zayed Sports City
Between entry gates 1 & 6
Abu Dhabi, United Arab Emirates
T:800 42532 (ICLDC)
F: +971 3 746 4900
PO Box 222464
Beside Tawam Hospital
Al Ain, United Arab Emirates
Consultant Endocrinologist and Diabetologist
Abu Dhabi
Dr Ahmed El-Laboudi is a leading exponent of new diabetes technology.
Through his work as a member of the Imperial College London Diabetes Technology group in the UK, he was awarded a PhD degree in the fields of continuous glucose monitoring (CGM) and glycaemic variability. He was at the forefront of research to develop a novel continuous glucose sensor aiming to improve the lives of type 1 diabetes patients.
His clinical and academic interests are type 1 diabetes, glycaemic variability and application of new technologies including insulin pump therapy, continuous glucose monitoring and artificial pancreas research. In Endocrinology, he has a special interest in pituitary, thyroid, parathyroid and adrenal diseases.
He has published several papers in peer-reviewed journals and presented his research in major international conferences. He is also passionate about medical education and has substantial teaching experience.
His career extends over 15 years working in some of the world-renowned clinical and academic centres of excellence in the UK, where he has worked as a consultant before joining ICLDC in 2017.
Languages Spoken: Arabic and English
